123 related articles for article (PubMed ID: 36404260)
1. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
de la Rubia J; González B; Cruz-Jentoft AJ; Iglesias L; Jarque I; Persona EP; Lluch R; Marrero C; Zudaire M; Gironella M; Hernández-Rivas JÁ; Arnan M; Olivier C; Encinas C; Soler JA; Payer ÁR; Casado A; Fernández P; Vilanova D; Bonanad S
J Geriatr Oncol; 2023 Jan; 14(1):101401. PubMed ID: 36404260
[TBL] [Abstract][Full Text] [Related]
2. Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.
Bonanad S; De la Rubia J; Gironella M; Pérez Persona E; González B; Fernández Lago C; Arnan M; Zudaire M; Hernández Rivas JA; Soler A; Marrero C; Olivier C; Altés A; Valcárcel D; Hernández MT; Oiartzabal I; Fernández Ordoño R; Arnao M; Esquerra A; Sarrá J; González-Barca E; González J; Calvo X; Nomdedeu M; García Guiñón A; Ramírez Payer A; Casado A; López S; Durán M; Marcos M; Cruz-Jentoft AJ;
J Geriatr Oncol; 2015 Sep; 6(5):353-61. PubMed ID: 26139300
[TBL] [Abstract][Full Text] [Related]
3. Further psychometric validation of the GAH scale: Responsiveness and effect size.
Cruz-Jentoft AJ; González B; de la Rubia J; Hernández Rivas JÁ; Soler JA; Fernández Lago C; Arnao M; Gironella M; Pérez Persona E; Zudaire MT; Olivier C; Altés A; García Guiñón A; Nomdedeu B; Arnan M; Ramírez Payer Á; Sánchez-Godoy P; Pajuelo N; Vilanova D; Monjil DF; Bonanad S;
J Geriatr Oncol; 2017 May; 8(3):211-215. PubMed ID: 28017687
[TBL] [Abstract][Full Text] [Related]
4. Patient General Condition at Diagnosis: A Systematic Evaluation for Adults Diagnosed with Hematologic Malignancies.
Ramos F; González-Carmona P; Porras-Guerra MI; Jiménez-Mola S; Martínez-Peláez AM; Blanco-Cabielles A; Conde S; Ahmadi A; Castellanos M; Cerdá S; de Las Heras N; Menéndez E; Escalante F; Fernández-Ferrero S; Lado T; Martínez-Robles V; Rondón F; Padilla I; Vidal MJ; Villalobos ML; Yacoubi S; Idoate-Gil FJ; Rodríguez-García JA
J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32867114
[TBL] [Abstract][Full Text] [Related]
5. Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies.
Garric M; Sourdet S; Cabarrou B; Steinmeyer Z; Gauthier M; Ysebaert L; Beyne-Rauzy O; Gerard S; Lozano S; Brechemier D; Filleron T; Mourey L; Balardy L
Eur J Haematol; 2021 May; 106(5):616-626. PubMed ID: 33340150
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice.
Ramos F; Hermosín ML; Fuertes-Núñez M; Martínez P; Rodriguez-Medina C; Barrios M; Ibáñez F; Bernal T; Olave MT; Álvarez MÁ; Vahí M; Caballero-Velázquez T; González B; Altés A; García L; Fernández P; Durán MA; López R; Rafel M; Serrano J
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138894
[TBL] [Abstract][Full Text] [Related]
7. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
[TBL] [Abstract][Full Text] [Related]
8. Validation of the G8 screening tool in older patients with aggressive haematological malignancies.
Velghe A; Petrovic M; De Buyser S; Demuynck R; Noens L
Eur J Oncol Nurs; 2014 Dec; 18(6):645-8. PubMed ID: 24954768
[TBL] [Abstract][Full Text] [Related]
9. Individualizing treatment decisions for older adults with hematologic malignancies.
Klepin HD; Rizzieri D; Palumbo A; Magarotto V; Eichhorst B
Am Soc Clin Oncol Educ Book; 2013; ():208-19. PubMed ID: 23714504
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary care in the hematology clinic: Implementation of geriatric oncology.
Goede V; Stauder R
J Geriatr Oncol; 2019 May; 10(3):497-503. PubMed ID: 30241779
[TBL] [Abstract][Full Text] [Related]
11. What do hematology residents know about caring for older adults with cancer? A national survey of Canadian hematology residents' knowledge and interests.
David V; Hsu T; Mithoowani S; Fraser G; Mian H
J Geriatr Oncol; 2022 Nov; 13(8):1236-1240. PubMed ID: 36050270
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
13. Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies.
Cavusoglu C; Tahtaci G; Dogrul RT; Ileri I; Yildirim F; Candemir B; Kizilarslanoglu MC; Uner A; Goker B
BMC Geriatr; 2021 Oct; 21(1):574. PubMed ID: 34666690
[TBL] [Abstract][Full Text] [Related]
14. Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy.
Hamaker ME; Augschoell J; Stauder R
Leuk Lymphoma; 2016 Nov; 57(11):2560-7. PubMed ID: 27050121
[TBL] [Abstract][Full Text] [Related]
15. Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper.
Loh KP; Christofyllakis K; Huang LW; Mims A
J Geriatr Oncol; 2019 Mar; 10(2):186-191. PubMed ID: 30661875
[No Abstract] [Full Text] [Related]
16. [Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors].
Atilla A; Çelik M; Çolak ÖY; Kuruoğlu T; Temoçin F; Kelkitli E; Birinci A
Mikrobiyol Bul; 2022 Apr; 56(2):315-325. PubMed ID: 35477233
[TBL] [Abstract][Full Text] [Related]
17. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
Kalicińska E; Kuszczak B; Dębski J; Szukalski Ł; Wątek M; Strzała J; Rybka J; Czyż J; Lech-Marańda E; Zaucha J; Wróbel T
Support Care Cancer; 2021 Jan; 29(1):323-330. PubMed ID: 32361829
[TBL] [Abstract][Full Text] [Related]
18. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Vasudevan Nampoothiri R; Pasic I; Law AD; Lam W; Chen C; Michelis FV; Kim DDH; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Eur J Haematol; 2022 May; 108(5):430-436. PubMed ID: 35100661
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
